110 related articles for article (PubMed ID: 16338621)
1. Differences in characteristics of US hematopoietic stem cell transplantation centers by proportion of racial or ethnic minorities.
Schwake CJ; Eapen M; Lee SJ; Freytes CO; Giralt SA; Navarro WH; Rizzo JD; van Besien K; Loberiza FR
Biol Blood Marrow Transplant; 2005 Dec; 11(12):988-98. PubMed ID: 16338621
[TBL] [Abstract][Full Text] [Related]
2. Effects of race on survival after stem cell transplantation.
Mielcarek M; Gooley T; Martin PJ; Chauncey TR; Young BA; Storb R; Torok-Storb B
Biol Blood Marrow Transplant; 2005 Mar; 11(3):231-9. PubMed ID: 15744242
[TBL] [Abstract][Full Text] [Related]
3. Disparity in survival outcome after hematopoietic stem cell transplantation for hematologic malignancies according to area of primary residence.
Rao K; Darrington DL; Schumacher JJ; Devetten M; Vose JM; Loberiza FR
Biol Blood Marrow Transplant; 2007 Dec; 13(12):1508-14. PubMed ID: 18022581
[TBL] [Abstract][Full Text] [Related]
4. The effect of the volume of procedures at transplantation centers on mortality after liver transplantation.
Edwards EB; Roberts JP; McBride MA; Schulak JA; Hunsicker LG
N Engl J Med; 1999 Dec; 341(27):2049-53. PubMed ID: 10615076
[TBL] [Abstract][Full Text] [Related]
5. [Effects and prognostic factors of HLA-matched sibling donor allogeneic hematopoietic stem cell transplantation for chronic myelogenous leukemia].
Tong XZ; Li J; Tan EX; Zhang GC; Wu XY; Peng AH; Zheng D; Zou WY; Hong WD; Luo SK
Zhonghua Zhong Liu Za Zhi; 2006 Jul; 28(7):545-8. PubMed ID: 17147125
[TBL] [Abstract][Full Text] [Related]
6. Allogeneic hematopoietic stem cell transplantation in myelofibrosis: the 20-year experience of the Gruppo Italiano Trapianto di Midollo Osseo (GITMO).
Patriarca F; Bacigalupo A; Sperotto A; Isola M; Soldano F; Bruno B; van Lint MT; Iori AP; Santarone S; Porretto F; Pioltelli P; Visani G; Iacopino P; Fanin R; Bosi A;
Haematologica; 2008 Oct; 93(10):1514-22. PubMed ID: 18728030
[TBL] [Abstract][Full Text] [Related]
7. [Umbilical cord blood as a source of stem cells].
Bojanić I; Golubić Cepulić B
Acta Med Croatica; 2006 Jun; 60(3):215-25. PubMed ID: 16933834
[TBL] [Abstract][Full Text] [Related]
8. Comparable long-term survival after unrelated and HLA-matched sibling donor hematopoietic stem cell transplantations for acute leukemia in children younger than 18 months.
Eapen M; Rubinstein P; Zhang MJ; Camitta BM; Stevens C; Cairo MS; Davies SM; Doyle JJ; Kurtzberg J; Pulsipher MA; Ortega JJ; Scaradavou A; Horowitz MM; Wagner JE
J Clin Oncol; 2006 Jan; 24(1):145-51. PubMed ID: 16382124
[TBL] [Abstract][Full Text] [Related]
9. Role of antithymocyte globulin and granulocyte-colony stimulating factor-mobilized bone marrow in allogeneic transplantation for patients with hematologic malignancies.
Chen XH; Zhang C; Zhang X; Gao L; Gao L; Kong PY; Peng XG; Qi DG; Sun AH; Zeng DF; Liu H; Gong Y; Wang QY
Biol Blood Marrow Transplant; 2009 Feb; 15(2):266-73. PubMed ID: 19167687
[TBL] [Abstract][Full Text] [Related]
10. Transplant center characteristics and clinical outcomes after hematopoietic stem cell transplantation: what do we know?
Loberiza FR; Serna DS; Horowitz MM; Rizzo JD
Bone Marrow Transplant; 2003 Mar; 31(6):417-21. PubMed ID: 12665834
[TBL] [Abstract][Full Text] [Related]
11. Late cardiovascular events after allogeneic hematopoietic stem cell transplantation: a retrospective multicenter study of the Late Effects Working Party of the European Group for Blood and Marrow Transplantation.
Tichelli A; Passweg J; Wójcik D; Rovó A; Harousseau JL; Masszi T; Zander A; Békássy A; Crawley C; Arat M; Sica S; Lutz P; Socié G;
Haematologica; 2008 Aug; 93(8):1203-10. PubMed ID: 18556401
[TBL] [Abstract][Full Text] [Related]
12. Racial/ethnic differences in patient experiences with and preferences for computed tomography colonography and optical colonoscopy.
Rajapaksa RC; Macari M; Bini EJ
Clin Gastroenterol Hepatol; 2007 Nov; 5(11):1306-12. PubMed ID: 17689294
[TBL] [Abstract][Full Text] [Related]
13. Is waiting time a measure of access to liver transplantation? Is shorter necessarily better?
Freeman RB
Hepatology; 2007 Aug; 46(2):602-3. PubMed ID: 17661416
[TBL] [Abstract][Full Text] [Related]
14. Association of transplant center and physician factors on mortality after hematopoietic stem cell transplantation in the United States.
Loberiza FR; Zhang MJ; Lee SJ; Klein JP; LeMaistre CF; Serna DS; Eapen M; Bredeson CN; Horowitz MM; Rizzo JD
Blood; 2005 Apr; 105(7):2979-87. PubMed ID: 15598815
[TBL] [Abstract][Full Text] [Related]
15. Results of genoidentical hemopoietic stem cell transplantation with reduced intensity conditioning for acute myelocytic leukemia: higher doses of stem cells infused benefit patients receiving transplants in second remission or beyond--the Acute Leukemia Working Party of the European Cooperative Group for Blood and Marrow Transplantation.
Gorin NC; Labopin M; Boiron JM; Theorin N; Littlewood T; Slavin S; Greinix H; Cahn JY; Alessandrino EP; Rambaldi A; Nagler A; Polge E; Rocha V;
J Clin Oncol; 2006 Aug; 24(24):3959-66. PubMed ID: 16880451
[TBL] [Abstract][Full Text] [Related]
16. Intensive care unit mortality trends in children after hematopoietic stem cell transplantation: a meta-regression analysis.
van Gestel JP; Bollen CW; van der Tweel I; Boelens JJ; van Vught AJ
Crit Care Med; 2008 Oct; 36(10):2898-904. PubMed ID: 18766109
[TBL] [Abstract][Full Text] [Related]
17. Comparable long-term survival after bone marrow versus peripheral blood progenitor cell transplantation from matched unrelated donors in children with hematologic malignancies.
Meisel R; Laws HJ; Balzer S; Bernbeck B; Kramm C; Schönberger S; Sinha K; Tröger A; Schmitz M; Fischer J; Göbel U; Enczmann J; Dilloo D
Biol Blood Marrow Transplant; 2007 Nov; 13(11):1338-45. PubMed ID: 17950920
[TBL] [Abstract][Full Text] [Related]
18. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
Petersen SL
Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
[TBL] [Abstract][Full Text] [Related]
19. Graft-versus-leukemia effect in hematopoietic stem cell transplantation for pediatric acute lymphoblastic leukemia: significantly lower relapse rate in unrelated transplantations.
Gassas A; Sung L; Saunders EF; Doyle J
Bone Marrow Transplant; 2007 Nov; 40(10):951-5. PubMed ID: 17873916
[TBL] [Abstract][Full Text] [Related]
20. KIR2DS5 is associated with leukemia free survival after HLA identical stem cell transplantation in chronic myeloid leukemia patients.
van der Meer A; Schaap NP; Schattenberg AV; van Cranenbroek B; Tijssen HJ; Joosten I
Mol Immunol; 2008 Aug; 45(13):3631-8. PubMed ID: 18555529
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
